Dynavax Technologies (DVAX) Stock: Here’s What You Need To Know

Dynavax Technologies (NASDAQ:DVAX) On Monday, Dynavax Technologies stock closed the day lower by 64.55% after the company announced that the FDA has rejected Hepislav-B, its lead vaccine product. This product is being used to treat patients with the Hepatitis B virus. Not many treatment options are available to those with the Hepatitis B virus, therefore … Read more

Biotech Stock News (MNKD) (SNY) (DVAX) (GSK) (AFFX) (TMO)

Mannkind Corporation (NASDAQ:MNKD) On Tuesday January 5th, 2016 shares of Mannkind fell by more than 48% after it was announced that the collaboration agreement by Sanofi (NYSE:SNY) had been terminated. This agreement was formed way back in 2014 where Sanofi made an upfront payment of $150 million. Sanofi was to take global rights for Afrezza, … Read more